ClinicalTrials.gg
CompletedNCT07051798Updated Mar 20, 2026

Phlebitis Experiences of Intensive Care Nurses

An observational study in Phlebitis and NursİNG CARE, sponsored by Kutahya Health Sciences University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Kutahya Health Sciences University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
20
Ages
18 Years to 50 Years
Sex
All
01

Study summary

It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses. This study is the first to be conducted in this respect, which constitutes the originality of the research. It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.

02

Conditions studied

  • Phlebitis
  • NursİNG CARE

Browse trials for

03

In context

Phlebitis

45 studies on the registry are indexed under Phlebitis; 9 are open to participants now.

Browse Phlebitis studies →

Lead sponsor

Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Intensive Care nurses

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntarily accepting to participate in the study
  • Being the primary nurse of a patient who developed phlebitis,
  • Having at least 1 year of work experience.

Exclusion criteria

Exclusion Criteria:

  • Being assigned to the unit for a short period of time
  • Being on leave or sick leave,
  • Not accepting to participate in the study,
  • Leaving the study during the data collection process.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
20 participants (actual)
Patient registry
No

Interventions

  • OtherIt is a qualitative type of study that will be conducted through face-to-face interviews.

    It is a qualitative type of study that will be conducted through face-to-face interviews.

06

What researchers measure

Primary outcomes

  1. Themes Identified in ICU Nurses' Experiences with Phlebitis Management

    Identification of distinct thematic categories from ICU nurses' experiences concerning the recognition, prevention, care practices, and clinical challenges related to phlebitis. Each theme will be extracted through thematic analysis of qualitative data obtained from semi-structured interviews. Method of Analysis: Braun \& Clarke's Thematic Analysis Method Unit of Measure: Number of distinct themes identified

    Time frame: Within the first 2 months following the initiation of the study

  2. Perceived Barriers and Facilitators in Phlebitis Management

    Evaluation and classification of ICU nurses' perceptions regarding institutional, educational, and individual-level factors affecting phlebitis assessment and management. Each perceived barrier or facilitator will be categorized based on content analysis of semi-structured interview transcripts. Method of Analysis: Content Analysis Methodology Unit of Measure: Number of identified barriers and facilitators.

    Time frame: Within 2 month after the completion of data collection

07

Study locations

1 site
  • Kutahya Health Sciences University
    Kütahya, Kütahya 43000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07051798
Responsible party
Sponsor
First posted
Jul 4, 2025
Start date
Jul 15, 2025
Primary completion
Aug 15, 2025
Completion
Mar 15, 2026
Last update
Mar 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion